Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WARRIOR: Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD
NCT03417388Phase 4Active, not recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Feb 2018
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of atorvastatin, rosuvastatin, lisinopril, losartan, aspirin in coronary artery disease (CAD), sponsored by Cedars-Sinai Medical Center. Started Feb 2018; status: active, not recruiting.
02
Drugs
atorvastatinrosuvastatinlisinoprillosartanaspirin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03417388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03417388.